Published 2021
| Version v1
Publication
Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting
Additional details
Identifiers
- URL
- http://hdl.handle.net/11567/1051444
- URN
- urn:oai:iris.unige.it:11567/1051444
Origin repository
- Origin repository
- UNIGE